FreeStyle Optium Blood Glucose Monitoring System

FreeStyle Optium is a globally recognized brand in the field of diabetes management, specifically known for its dual-function meters that measure both blood glucose and blood ketone levels. The brand has its roots in the technological innovations of the late 20th century aimed at making blood testing more accessible and less painful for patients. The development of 'side-fill' and 'zip-wick' technology for test strips became a hallmark of the FreeStyle line, setting it apart from competitors by requiring much smaller blood samples.

The brand was originally developed by TheraSense, a California-based medical technology company founded in 1996. TheraSense's success in the glucose monitoring market led to its high-profile acquisition by Abbott Laboratories in 2004 for approximately $1.2 billion. This acquisition integrated FreeStyle into Abbott's Diabetes Care division, providing the brand with the global reach and research capabilities of one of the world's largest healthcare companies.

Today, FreeStyle Optium products are manufactured across a global network of specialized medical device facilities, with significant production occurring in the United Kingdom, Ireland, and the United States. As of 2026, the brand remains an essential part of the Abbott Diabetes Care portfolio, continuing to evolve with integrated digital health features and connectivity to mobile applications for comprehensive patient data management.